Role of c-Jun N-terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage

Stroke

Volumn 36, Issue 7, 2005, Pages 1538-1543

  Yatsushige, Hiroshi ^a,c,d,e   Yamaguchi, Mitsuo ^a,c   Zhou, Changman ^a   Calvert, John W ^a,c   Zhang, John H ^a,b,c  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^c Louisiana State University School of Medicine Shreveport   (United States)

^d NATIONAL HOSPITAL ORGANIZATION DISASTER MEDICAL CENTER   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cerebral vasospasm; Inflammation; JNK; Subarachnoid hemorrhage

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CONTRAST MEDIUM; CYTOKINE; DIMETHYL SULFOXIDE; INTERLEUKIN 6; IODIXANOL; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CEREBROSPINAL FLUID LEVEL; CISTERNA MAGNA; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOG; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INJECTION SITE; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING;

ANGIOGRAPHY; ANIMALS; ANTHRACENES; BLOTTING, WESTERN; CYTOKINES; DIMETHYL SULFOXIDE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEMORRHAGE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKOCYTES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASOSPASM, INTRACRANIAL;

EID: 22044455107     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000170713.22011.c8     Document Type: Article

References (23)

1. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS. Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery. 2003;53:123-135.
2. Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol. 2002;88:227-249.
3. Sasaki T, Kasuya H, Onda H, Sasahara A, Goto S, Hori T, Inoue I. Role of p38 mitogen-activated protein kinase on cerebral vasospasm after subarachnoid hemorrhage. Stroke. 2004;35:1466-1470.
4. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS. C-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest. 2001;108:73-81.
5. Eynott PR, Nath P, Leung SY, Adcock IM, Bennett BL, Chung KF. Allergen-induced inflammation and airway epithelial and smooth muscle cell proliferation: role of jun n-terminal kinase. Br J Pharmacol. 2003; 140:1373-1380.
6. Yamaguchi M, Zhou C, Heistad DD, Watanabe Y, Zhang JH. Gene transfer of extracellular superoxide dismutase failed to prevent cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke. 2004; 35:2512-2517.
7. Yamaguchi M, Zhou C, Nanda A, Zhang JH. Ras protein contributes to cerebral vasospasm in a canine double-hemorrhage model. Stroke. 2004; 35:1750-1755.
8. Zhou C, Yamaguchi M, Kusaka G, Schonholz C, Nanda A, Zhang JH. Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24:419-431.
9. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW. Sp600125, an anthrapyrazolone inhibitor of jun n-terminal kinase. Proc Natl Acad Sci USA. 2001;98:13681-13686.
10. Su X, Bai C, Hong Q, Zhu D, He L, Wu J, Ding F, Fang X, Matthay MA. Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury. Intensive Care Mid. 2003;29:2034-2042.
11. Manning AM, Davis RJ. Targeting jnk for therapeutic benefit: From junk to gold? Nat Rev Drug Discov. 2003;2:554-565.
12. Kusaka G, Ishikawa M, Nanda A, Granger DN, Zhang JH. Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24:916-925.
13. Kubota T, Handa Y, Tsuchida A, Kaneko M, Kobayashi H. The kinetics of lymphocyte subsets and macrophages in subarachnoid space after subarachnoid hemorrhage in rats. Stroke, 1993;24:1993-2001.
14. Sullivan GW, Sarembock IJ, Linden J. The role of inflammation in vascular diseases. J Leukoc Biol. 2000;67:591-602.
15. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, Fritzinger M, Horn P, Vajkoczy P, Wendel-Wellner M, Ragoschke A, Kuehl S, Brunner J, Schurer L, Schmiedeck P, Kennerici M. Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke. 2000;31:2971-2975.
16. Holzberg D, Knight CG, Dittrich-Breiholz O, Schneider H, Dorrie A, Hoffmann E, Resch K, Kracht M. Disruption of the c-Jun-JNK complex by a cell-permeable peptide containing the c-Jun delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes. J Biol Chem. 2003;278:40213-40223.
17. Oshiro EM, Hoffman PA, Dietsch GN, Watts MC, Pardoll DM, Tamargo RJ. Inhibition of experimental vasospasm with anti-intercellular adhesion molecule-1 monoclonal antibody in rats. Stroke. 1997;28:2031-2038.
18. Kikuchi T, Okuda Y, Kaito N, Abe T. Cytokine production in cerebro-spinal fluid after subarachnoid haemorrhage. Neurol Res. 1995;17: 106-108.
19. Kwon KY, Jeon BC. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci. 2001;16:774-780.
20. Mathiesen T, Edner G, Ulfarsson E, Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg. 1997;87:215-220.
21. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, Fritzinger M, Horn P, Vajkoczy P, Kreisel S, Brunner J, Schmiedek P, Hennerici M. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70:534-537.
22. Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M, Shibuya M, Yoshida J. Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien). 1998;140:943-951.
23. Bowman G, Dixit S, Bonneau RH, Chinchilli VM, Cockroft KM. Neutralizing antibody against interleukin-6 attenuates posthemorrhagic vasospasm in the rat femoral artery model. Neurosurgery. 2004;54: 719-726.